Commentary / World Nov 16, 2022
New weight-loss drugs work, but who's paying?
by Lisa Jarvis
Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren’t yet on board.
New weight-loss drugs work, but who's paying?
Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren’t yet on board.
Weed is now legal in Thailand. How long will the high times last?
Cannabis shops have multiplied since the drug was decriminalized, with caveats, in June. But some lawmakers are pushing for tighter regulation.
In a statement, the WNBA star's lawyers said it would be some time before she was moved to a prison colony, and that they had not yet decided whether to try to launch another appeal.
Israeli charged with smuggling drugs into Japan dies in detention
Amnon Hanoh Tenenboim was refused special treatment even though he was suspected of having a heart condition, his lawyer said.
Why strict but inconsistent gun laws did not keep Thailand safe
The murder of two dozen small children — committed during nap time in colorful classrooms — has horrified the nation.
Mass killing at Thai preschool prompts calls for drug crackdown
Former Prime Minister Thaksin Shinawatra urged the government to "speed up the suppression of drugs, especially methamphetamine tablets.”
Japan should consider allowing medical cannabis, health panel says
Japan should consider approving the import, manufacture and use of medicines derived from cannabis, a health ministry panel said.
From the bones of victims, a doctor unearths the Philippine drug war’s true toll
Forensic pathologist Raquel Fortun is using her skills to show how other doctors falsely claimed some victims of the country’s drug war had died natural deaths.
Japan’s anticipated approval of medical abortion pills may come with a hurdle, requiring women to get approval from their partners before doctors will give them the drugs.
With a $2.1 million cure their only hope, Indian parents plead for help online
India makes many of the world’s drugs, but treatments for rare diseases like spinal muscular atrophy are imported and prohibitively costly.
Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug
The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.
Confronting AI’s potential to create new chemical weapons
Although the immediate danger seems minimal, efforts are needed to safeguard machine-learning models used in chemical and drug discovery.